The effectiveness of non-clinical drug safety predictions is enhanced by the adoption of three-dimensional (3D) cellular models. 3D bioprinting enables the generation of complex models with spatial ...

In the world of medical advancements, 3D-printed organs have made a significant stride. Latest trials have demonstrated that these bioengineered organs can maintain their function for up to six months ...

Spheroids Market revenue is expected to grow at a CAGR of 23.3% from 2025 to 2032, reaching nearly USD 4183.33 Mn by 2032. Spheroids are no longer just lab models, they’re catalysts accelerating drug ...

This breakthrough combines 3D bioprinting, organoid technology, and placental research. It may pave the way for safer drugs, ...

Research and drug discovery are undergoing a transformation, driven by the rise of 3D cell culture models that better replicate human biology. Unlike traditional 2D cultures and animal models, which ...

TheWell Bioscience Inc., a leader in advanced 3D cell culture platform for precision medicine, cell therapy and ...

Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in vitro ...

Scientists have successfully immortalized lip cells, allowing new treatments for injuries and infections to be trialed on a clinically relevant lab-based model We use our lips to talk, eat, drink, and ...

Article reviewed by Julía Crispim da Fontoura, a PhD candidate at the Federal University of Health Sciences of Porto Alegre, Brazil who uses organoids to study drug resistance. Stay up to date on the ...

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life ...